Coller Capital expands in South-east Asia private equity secondary market with Singapore office

Coller Capital expands in South-east Asia private equity secondary market with Singapore office

The move extends the company’s commitment to the region as demand rises.

Coller Capital expands Asia Pacific reach with Singapore office launch, brings in Partners Group's Wu

Secondaries investment major Coller Capital has expanded to Singapore with the opening of its fifth office in the Asia Pacific region. The post Coller Capital expands Asia Pacific reach with Singapore office launch, brings in Partners Group’s Wu appeared first on AltAssets Private Equity News.

Coller Capital launches Singapore office

Coller Capital has established its first Singapore office as it expands its presence in Southeast Asia. The private market secondaries specialist has also announced the appointment of Peter Wu as head of product management, private wealth, based in Singapore. Wu has more than 14 years of industry experience and was previously global head of product […] The post Coller Capital launches Singapore office appeared first on Alternative Credit Investo…

Coller Capital launches new office in Singapore

Secondaries manager Coller Capital has expanded its global footprint by establishing a new office in Singapore, aiming to meet the needs of the institutional and private wealth investor bases in Southeast Asia. Peter Wu takes on the role of head of product management, private wealth, joined by two local investor relations colleagues, collaborating with the private wealth secondaries solutions (PWSS) team. Wu, who earlier worked at Partners Group…

Coller Capital expands in South-east Asia’s private equity secondary market with Singapore office

LONDON-headquartered Coller Capital, one of the largest global investors in the private equity (PE) secondary market, is setting up an office in Singapore amid growing demand from institutional and private wealth investors in South-east Asia.

China’s Sirio Pharma beefs up SEA presence with new Thai plant, Singapore office

China’s Sirio Pharma is ramping up its presence in South East Asia (SEA), with the pending construction of a gummy production plant in Thailand and office in Singapore’s central business district.